Protein Sciences Corporation, a leading entity in the biotechnology industry, is headquartered in the United States. Founded in 1983, the company has made significant strides in the development of innovative protein-based solutions, particularly in the fields of vaccine production and biopharmaceuticals. With a focus on advanced protein expression systems, Protein Sciences is renowned for its proprietary technologies, which enhance the efficiency and safety of vaccine manufacturing. Their flagship product, the Flublok® vaccine, stands out for its unique recombinant technology, offering a more effective alternative to traditional flu vaccines. Recognised for its commitment to quality and innovation, Protein Sciences has established a strong market position, contributing to public health initiatives and advancing the biotechnology landscape. The company continues to play a pivotal role in addressing global health challenges through its cutting-edge research and development efforts.
How does Protein Sciences Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Protein Sciences Corporation's score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Protein Sciences Corporation, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Sanofi, and as such, it inherits emissions data and climate commitments from its parent organisation. While no absolute emissions figures are provided, Protein Sciences Corporation aligns its climate initiatives with those of Sanofi, which has established various reduction targets and commitments. These include participation in the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, all of which are cascaded from Sanofi at a corporate family level. Despite the absence of specific emissions data, Protein Sciences Corporation is committed to sustainability and reducing its carbon footprint in line with industry standards. The company is expected to follow the climate strategies and reduction targets set by Sanofi, which are designed to mitigate climate impact and promote environmental responsibility.
Access structured emissions data, company-specific emission factors, and source documents
| 2010 | 2011 | 2012 | 2013 | 2015 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 545,114,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 
| Scope 2 | 677,549,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 
| Scope 3 | - | - | - | 0,000,000,000 | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 
Protein Sciences Corporation's Scope 3 emissions, which decreased by 5% last year and increased by approximately 40% since 2013, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 69% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Protein Sciences Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.